Cargando…

561. Recombinant Adenovirus Carrying Spike Gene Induces Effective Humoral and Cellular Immunity Against SARS-CoV in Rats

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Gene Therapy. Published by Elsevier Inc. 2004
Materias:	Infectious Diseases and Vaccines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128984/ http://dx.doi.org/10.1016/j.ymthe.2004.06.487

Ejemplares similares

558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus
Publicado: (2004)

Evidence for Aerosol Transfer of SARS-CoV-2–Specific Humoral Immunity
por: Kedl, Ross M., et al.
Publicado: (2023)

SARS-CoV-2 Vaccination in Kidney Transplant Recipients—Stratified Analysis of the Humoral Immune Response
por: Lammert, Alexander, et al.
Publicado: (2022)

Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients
por: Marion, Olivier, et al.
Publicado: (2021)

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses
por: Falloon, Judith, et al.
Publicado: (2017)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Avoiding culture shock with the SARS-CoV-2 spike protein
por: Hale, Benjamin G
Publicado: (2021)

Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
por: Díaz-Salinas, Marco A, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant Variant
por: Karyakarte, Rajesh P, et al.
Publicado: (2023)

Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2023)

Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, India
por: Karyakarte, Rajesh P, et al.
Publicado: (2023)

Antiviral Activity of Svarnvir-IV Tablet Assayed for Activity Against SARS-CoV-2 In Vitro
por: Reddy, K. Ramachandra, et al.
Publicado: (2023)

SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Imhof, Céline, et al.
Publicado: (2022)

Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease
por: Deschambault, Yvon, et al.
Publicado: (2022)

Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort Study
por: Cucchiari, David, et al.
Publicado: (2022)

mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant
por: Parry, Helen, et al.
Publicado: (2021)

Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein
por: Geng, Qibin, et al.
Publicado: (2023)

Radiographic findings of SARS‐CoV‐2 infection
por: Marco, Catherine A., et al.
Publicado: (2021)

A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol
por: Xiao, Tiantian, et al.
Publicado: (2020)

SARS-CoV-2 Seroprevalence at an Urban Hospital in Haiti
por: Price, Robert, et al.
Publicado: (2022)

Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)
por: Yahav, Dafna, et al.
Publicado: (2021)

Assessment of humoral and cell-mediated immune responses to pertussis vaccination: a systematic review protocol
por: Akinola, Funbi, et al.
Publicado: (2019)

Stronger together: Analytical techniques for recombinant adeno associated virus
por: Hutanu, Andrei, et al.
Publicado: (2021)

Evolutionary Perspective and Theories on the Possible Origin of SARS-CoV-2
por: Saeed, Amanj A
Publicado: (2021)

Attenuation and Degeneration of SARS-CoV-2 Despite Adaptive Evolution
por: Liu, Yingguang
Publicado: (2023)

Two-Hit Kidney Allograft Injury by SARS-CoV-2
por: Ribeiro, Bárbara, et al.
Publicado: (2023)

Environmental Contamination With SARS-CoV-2 in a Hospital Setting
por: Kumar, Sumit, et al.
Publicado: (2023)

An Overview of Fluvoxamine and its Use in SARS-CoV-2 Treatment
por: Arishi, Naif A, et al.
Publicado: (2023)

Community-Based Seroprevelance of SARS-CoV-2 in Saudi Arabia
por: Alassaf, Lujain, et al.
Publicado: (2022)

Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative case–control study
por: Khan, Unab Inayat, et al.
Publicado: (2023)

Neuropathological findings from COVID‐19 patients with neurological symptoms argue against a direct brain invasion of SARS‐CoV‐2: A critical systematic review
por: Cosentino, Giuseppe, et al.
Publicado: (2021)

Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up
por: Adriaenssens, Niels, et al.
Publicado: (2022)

Transmission of SARS-CoV-2 in educational settings in 2020: a review
por: Vardavas, Constantine, et al.
Publicado: (2022)

Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
por: Alhaddad, Fatemah, et al.
Publicado: (2022)

The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
por: DeGrasse, David C, et al.
Publicado: (2023)

Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey
por: Temsah, Mohamad-Hani, et al.
Publicado: (2021)

Recombinant Human Thrombomodulin Reduces Mortality and Acute Lung Injury Caused by Septic Peritonitis in Rats
por: Kono, Hiroshi, et al.
Publicado: (2023)

Patient factors associated with SARS‐CoV‐2 in an admitted emergency department population
por: Haimovich, Adrian D., et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
por: Pal, Mahendra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_54j64a17i78fr1tmi0ovg0qlcp